Skip to content
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Nephrology

The Diagnostic Process and Avoiding Misdiagnoses

At a Glance

Fanconi Renotubular Syndrome 1 is diagnosed by a pattern of kidney-tubule losses, such as glucose in urine despite normal blood sugar, phosphate wasting, and amino acids in urine, together with clinical findings and a pathogenic or likely pathogenic change in the GATM gene.

Getting to a diagnosis of Fanconi Renotubular Syndrome 1 (FRTS1) is often a process of elimination. Because it is so rare, it is frequently mistaken for more common conditions that cause similar symptoms [1][2]. Understanding how doctors prove the kidneys are “leaking” and how genetic testing is integrated can help you navigate this complex journey.

Proving Proximal Tubule Dysfunction

The first step in diagnosis isn’t a single test, but a pattern of results showing that the proximal tubules (the kidney’s recycling centers) aren’t doing their job [3][4]. A normal overall kidney function number (normal eGFR or creatinine) does not rule out Fanconi syndrome. Doctors look for a combination of “leaks” in the urine, including:

  • Glucosuria with Normoglycemia: This is a hallmark sign—finding sugar (glucose) in the urine while blood sugar levels are perfectly normal [5][6].
  • Generalized Aminoaciduria: Losing a wide variety of amino acids (protein building blocks) in the urine [3][7].
  • Phosphate Wasting: Clinicians use paired blood and urine measurements (like fractional excretion or TmP/GFR) to show the kidneys are inappropriately losing phosphate [6][8].
  • Low-Molecular-Weight Proteinuria: A specific type of protein loss that indicates the tubules, not the kidney’s main filters, are damaged [4][9].
  • Hypouricemia: Abnormally low levels of uric acid in the blood because it is being lost in the urine [3][10].

Avoiding Common Misdiagnoses

FRTS1 is a “look-alike” for several other conditions. Distinguishing between them is vital because the treatments and long-term risks are different [1].

  • Cystinosis: This is the most common cause of Fanconi syndrome in children. Unlike FRTS1, it affects many organs and requires an eye exam to look for cystine crystals in the cornea [11][12].
  • Dent Disease: An X-linked condition (mostly affecting boys) that also causes protein and mineral leaks but has a different genetic cause (CLCN5 or OCRL genes) [13][14].
  • Other Causes of Rickets: Many children are initially treated for simple Vitamin D deficiency. If the rickets do not improve with standard Vitamin D, doctors should look for genetic causes (like FRTS1 or FGF23-mediated disorders) [8][1].
  • Acquired Tubulopathy: In adults, certain medications (like some antivirals) or heavy metal exposure can mimic FRTS1 symptoms [3][15].

The Role of Genetic Testing

While lab tests show the kidneys are leaking, genetic testing combined with clinical findings is used to pinpoint the exact cause [1].

  • The GATM Gene: FRTS1 is specifically caused by a mutation in the GATM gene [1][16].
  • Inheritance: It is an autosomal dominant condition, meaning it can be passed from just one parent to a child, or it can happen for the first time in a child (a de novo mutation) [17][16].
  • Definitive Result: Finding a “pathogenic” or “likely pathogenic” variant in the GATM gene, when matched with symptoms, provides a definitive diagnosis. A “Variant of Uncertain Significance” (VUS) does not confirm the diagnosis [18][19].

Clinician-Selected Diagnostic Workup

If your medical team suspects Fanconi syndrome, they may select from the following tests. (Note: Not every patient needs every test, and interpretation requires specialist expertise).

Blood Tests

  • Electrolytes (specifically Potassium and Bicarbonate/CO2) [3][4]
  • Phosphate and Calcium [8][20]
  • Creatinine/eGFR (to check overall kidney filtration) [18][21]
  • Uric Acid [3][10]
  • Alkaline Phosphatase and PTH (markers for bone activity) [8][20]
  • Glucose (to compare with urine glucose) [5]

Urine Tests

  • Urinalysis (checking for glucose and protein) [5]
  • Fractional Excretion of Phosphate (paired with blood tests) [6]
  • Amino Acid Profile [3]
  • Protein/Creatinine Ratio (with a focus on low-molecular-weight proteins) [4]

Imaging & Specialty

  • Bone X-rays (to check for signs of rickets or thinning) [22][23]
  • Kidney Ultrasound (to look for calcium deposits or stones) [24]
  • Genetic Panel (specifically including the GATM gene) [18][1]

Common questions in this guide

How is Fanconi Renotubular Syndrome 1 diagnosed?
Doctors look for a pattern showing that the kidney’s proximal tubules are losing substances such as glucose, phosphate, amino acids, and certain proteins. A pathogenic or likely pathogenic GATM gene variant that matches the clinical findings supports the diagnosis, while normal creatinine or eGFR does not rule it out.
What does glucose in the urine mean when blood sugar is normal?
Glucose in the urine despite normal blood sugar suggests that the kidney’s proximal tubules are not reabsorbing glucose properly. It is different from the usual pattern caused by high blood sugar and can be an important clue to Fanconi syndrome, including FRTS1.
What conditions can be mistaken for FRTS1?
Cystinosis, Dent disease, some genetic causes of rickets, and acquired tubule damage from certain medicines or heavy metals can cause similar urine and mineral abnormalities. Doctors may use eye examinations, targeted genetic testing, treatment history, and exposure history to help distinguish them.
What does a GATM variant of uncertain significance mean?
A variant of uncertain significance, or VUS, has not been shown to cause FRTS1 and does not confirm the diagnosis by itself. A pathogenic or likely pathogenic GATM variant is more meaningful when it fits the person’s laboratory findings and clinical history.
Which tests may be included in an FRTS1 diagnostic workup?
The workup may include blood tests for electrolytes, phosphate, calcium, uric acid, glucose, kidney function, and bone-related markers, along with urine testing for glucose, phosphate loss, amino acids, and low-molecular-weight proteins. Depending on the findings, clinicians may also order bone X-rays, a kidney ultrasound, and genetic testing that includes GATM.
Can Fanconi Renotubular Syndrome 1 be inherited?
FRTS1 is described as an autosomal dominant condition, so a pathogenic GATM variant can be inherited from one parent. It can also result from a new, or de novo, variant, so it may occur even without a known family history.

Get notified when new evidence is published on Fanconi renotubular syndrome 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (24)
  1. 1

    Complex phenotype in Fanconi renotubular syndrome type 1: Hypophosphatemic rickets as the predominant presentation.

    Li CY, Sun Y, Guo WC, et al.

    Clinica chimica acta; international journal of clinical chemistry 2024; (561()):119812 doi:10.1016/j.cca.2024.119812.

    PMID: 38876250
  2. 2

    Inherited Fanconi renotubular syndromes: unveiling the intricacies of hypophosphatemic rickets/osteomalacia.

    Ragate DC, Memon SS, Karlekar M, et al.

    Journal of bone and mineral metabolism 2024; (42(2)):155-165 doi:10.1007/s00774-023-01490-3.

    PMID: 38310177
  3. 3

    Fanconi Syndrome.

    Foreman JW

    Pediatric clinics of North America 2019; (66(1)):159-167 doi:10.1016/j.pcl.2018.09.002.

    PMID: 30454741
  4. 4

    Proximal renal tubular acidosis with and without Fanconi syndrome.

    Kashoor I, Batlle D

    Kidney research and clinical practice 2019; (38(3)):267-281 doi:10.23876/j.krcp.19.056.

    PMID: 31474092
  5. 5

    Clinical Approach to Proximal Renal Tubular Acidosis in Children.

    Finer G, Landau D

    Advances in chronic kidney disease 2018; (25(4)):351-357 doi:10.1053/j.ackd.2018.05.006.

    PMID: 30139461
  6. 6

    Fumaric acid ester-induced renal Fanconi syndrome: evidence of mitochondrial toxicity.

    Wan ER, Siew K, Heptinstall L, Walsh SB

    Clinical kidney journal 2021; (14(9)):2085-2089 doi:10.1093/ckj/sfaa270.

    PMID: 35261762
  7. 7

    Rickets in proximal renal tubular acidosis: a case series of six distinct etiologies.

    Singhania P, Dhar A, Deshpande A, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(9)):879-885 doi:10.1515/jpem-2023-0155.

    PMID: 37434360
  8. 8

    Case report: Reversible Fanconi syndrome due to vitamin D deficiency in a patient with epilepsy harbouring a pathogenic variant in the SLC34A1 gene.

    Improda N, Rosanio FM, Annicchiarico Petruzzelli L, et al.

    Frontiers in endocrinology 2025; (16()):1553032 doi:10.3389/fendo.2025.1553032.

    PMID: 40225330
  9. 9

    Association of Familial Fanconi Syndrome with a Novel GATM Variant.

    Kudo H, Suzuki R, Kondo A, et al.

    The Tohoku journal of experimental medicine 2023; (260(4)):337-340 doi:10.1620/tjem.2023.J046.

    PMID: 37286521
  10. 10

    Adult-Onset Fanconi Syndrome Presenting as Stress Fractures: A Case Report.

    Gupta S, Kamat N, Shenoy DV, Agarwal S

    Journal of orthopaedic case reports 2025; (15(12)):32-35 doi:10.13107/jocr.2025.v15.i12.6444.

    PMID: 41509769
  11. 11

    Effects of long-term cysteamine treatment in patients with cystinosis.

    Ariceta G, Giordano V, Santos F

    Pediatric nephrology (Berlin, Germany) 2019; (34(4)):571-578 doi:10.1007/s00467-017-3856-4.

    PMID: 29260317
  12. 12

    Diagnostic challenge in a patient with nephropathic juvenile cystinosis: a case report.

    Higashi S, Matsunoshita N, Otani M, et al.

    BMC nephrology 2017; (18(1)):300 doi:10.1186/s12882-017-0721-4.

    PMID: 28950840
  13. 13

    Multicenter study of the clinical features and mutation gene spectrum of Chinese children with Dent disease.

    Ye Q, Shen Q, Rao J, et al.

    Clinical genetics 2020; (97(3)):407-417 doi:10.1111/cge.13663.

    PMID: 31674016
  14. 14

    Clinical variation in Lowe syndrome: what and how?

    Brewer ED

    Frontiers in cell and developmental biology 2025; (13()):1720452 doi:10.3389/fcell.2025.1720452.

    PMID: 41278199
  15. 15

    Drug-induced Fanconi syndrome in patients with kidney allograft transplantation.

    Tang Z, Li T, Dai H, et al.

    Frontiers in immunology 2022; (13()):979983 doi:10.3389/fimmu.2022.979983.

    PMID: 36059468
  16. 16

    Glycine Amidinotransferase (GATM), Renal Fanconi Syndrome, and Kidney Failure.

    Reichold M, Klootwijk ED, Reinders J, et al.

    Journal of the American Society of Nephrology : JASN 2018; (29(7)):1849-1858 doi:10.1681/ASN.2017111179.

    PMID: 29654216
  17. 17

    Renal proteomic landscape of a patient with Fanconi renotubular syndrome carrying a novel GATM variant.

    Lu F, Yang L, Qian S, et al.

    Frontiers in physiology 2026; (17()):1921122 doi:10.3389/fphys.2026.1921122.

    PMID: 42845598
  18. 18

    Genetic Screening of Patients With Inherited Fanconi Syndrome.

    Inoki Y, Sakakibara N, Yamamoto A, et al.

    Kidney international reports 2026; (11(7)):106576 doi:10.1016/j.ekir.2026.106576.

    PMID: 42282999
  19. 19

    Simultaneous sequencing of 37 genes identified causative mutations in the majority of children with renal tubulopathies.

    Ashton EJ, Legrand A, Benoit V, et al.

    Kidney international 2018; (93(4)):961-967 doi:10.1016/j.kint.2017.10.016.

    PMID: 29398133
  20. 20

    Renal Fanconi syndrome and vitamin D deficiency: chicken or egg?

    Zerrouki S, Soyalp G, Taillandier L, et al.

    Pediatric nephrology (Berlin, Germany) 2026; (41(10)):3591-3594 doi:10.1007/s00467-026-07347-x.

    PMID: 42069983
  21. 21

    Refractory Rickets: Evaluation and Management.

    Krishnamurthy S

    Indian journal of pediatrics 2026; (93(6)):612-620 doi:10.1007/s12098-026-06032-z.

    PMID: 41741919
  22. 22

    Rickets guidance: part II-management.

    Haffner D, Leifheit-Nestler M, Grund A, Schnabel D

    Pediatric nephrology (Berlin, Germany) 2022; (37(10)):2289-2302 doi:10.1007/s00467-022-05505-5.

    PMID: 35352187
  23. 23

    Management of bone disease in cystinosis: Statement from an international conference.

    Hohenfellner K, Rauch F, Ariceta G, et al.

    Journal of inherited metabolic disease 2019; (42(5)):1019-1029 doi:10.1002/jimd.12134.

    PMID: 31177550
  24. 24

    Skeletal Consequences of Nephropathic Cystinosis.

    Florenzano P, Ferreira C, Nesterova G, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2018; (33(10)):1870-1880 doi:10.1002/jbmr.3522.

    PMID: 29905968

This page is for informational purposes only and does not constitute medical advice. A nephrologist or genetics professional should interpret your or your child’s test results and discuss next steps.